4//SEC Filing
Wilson Martin 4
Accession 0001140361-25-032090
CIK 0001281895other
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 5:00 PM ET
Size
6.2 KB
Accession
0001140361-25-032090
Insider Transaction Report
Form 4
Wilson Martin
General Counsel
Transactions
- Sale
Common Stock
2025-08-18$3.06/sh−1,004$3,077→ 136,050 total - Sale
Common Stock
2025-08-19$3.00/sh−588$1,762→ 135,462 total
Footnotes (2)
- [F1]Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
- [F2]The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
Documents
Issuer
ROCKET PHARMACEUTICALS, INC.
CIK 0001281895
Entity typeother
Related Parties
1- filerCIK 0001704342
Filing Metadata
- Form type
- 4
- Filed
- Aug 19, 8:00 PM ET
- Accepted
- Aug 20, 5:00 PM ET
- Size
- 6.2 KB